Cargando…

Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19)()

The coronavirus 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has had enormous health, economic, and social consequences. The clinical spectrum of cutaneous manifestations observed in patients with COVID-19 is both heterogeneous and complex. To dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Carrascosa, J.M., Morillas, V., Bielsa, I., Munera-Campos, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier España, S.L.U. on behalf of AEDV. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560260/
http://dx.doi.org/10.1016/j.adengl.2020.10.001
_version_ 1783595046208012288
author Carrascosa, J.M.
Morillas, V.
Bielsa, I.
Munera-Campos, M.
author_facet Carrascosa, J.M.
Morillas, V.
Bielsa, I.
Munera-Campos, M.
author_sort Carrascosa, J.M.
collection PubMed
description The coronavirus 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has had enormous health, economic, and social consequences. The clinical spectrum of cutaneous manifestations observed in patients with COVID-19 is both heterogeneous and complex. To date, reports have identified 5 main categories: acral lesions, vesicular rashes, urticarial rashes, maculopapular rashes, and livedoid and necrotic lesions. However, these will probably be modified as new information comes to light. Cutaneous manifestations associated with COVID-19 probably reflect the activation of pathogenic pathways by the virus or a response to inflammatory processes, vascular or systemic complications, or even treatments. Familiarity with the cutaneous manifestations of COVID-19 may enable early diagnosis or help guide prognosis.
format Online
Article
Text
id pubmed-7560260
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Published by Elsevier España, S.L.U. on behalf of AEDV.
record_format MEDLINE/PubMed
spelling pubmed-75602602020-10-16 Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19)() Carrascosa, J.M. Morillas, V. Bielsa, I. Munera-Campos, M. Actas Dermosifiliogr Novelties in Dermatology The coronavirus 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has had enormous health, economic, and social consequences. The clinical spectrum of cutaneous manifestations observed in patients with COVID-19 is both heterogeneous and complex. To date, reports have identified 5 main categories: acral lesions, vesicular rashes, urticarial rashes, maculopapular rashes, and livedoid and necrotic lesions. However, these will probably be modified as new information comes to light. Cutaneous manifestations associated with COVID-19 probably reflect the activation of pathogenic pathways by the virus or a response to inflammatory processes, vascular or systemic complications, or even treatments. Familiarity with the cutaneous manifestations of COVID-19 may enable early diagnosis or help guide prognosis. Published by Elsevier España, S.L.U. on behalf of AEDV. 2020-11 2020-10-15 /pmc/articles/PMC7560260/ http://dx.doi.org/10.1016/j.adengl.2020.10.001 Text en © 2020 Published by Elsevier España, S.L.U. on behalf of AEDV. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Novelties in Dermatology
Carrascosa, J.M.
Morillas, V.
Bielsa, I.
Munera-Campos, M.
Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19)()
title Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19)()
title_full Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19)()
title_fullStr Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19)()
title_full_unstemmed Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19)()
title_short Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19)()
title_sort cutaneous manifestations in the context of sars-cov-2 infection (covid-19)()
topic Novelties in Dermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560260/
http://dx.doi.org/10.1016/j.adengl.2020.10.001
work_keys_str_mv AT carrascosajm cutaneousmanifestationsinthecontextofsarscov2infectioncovid19
AT morillasv cutaneousmanifestationsinthecontextofsarscov2infectioncovid19
AT bielsai cutaneousmanifestationsinthecontextofsarscov2infectioncovid19
AT muneracamposm cutaneousmanifestationsinthecontextofsarscov2infectioncovid19